首页> 外文期刊>The Journal of laryngology and otology. >The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.
【24h】

The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.

机译:经验性质子泵抑制剂试验与24小时双探头Ph监测喉咽返流的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Laryngopharyngeal reflux (LPR), which is defined as the backflow of gastric contents into the upper aerodigestive tract, is a relatively common disorder. However, its diagnosis still poses many problems. Twenty-four-hour double-probe pH monitoring is currently the diagnostic test of choice, but it has many disadvantages. Thus, an empiric trial of antireflux therapy has been suggested as an alternative method for diagnosis. The purpose of this article is to evaluate the validity of this alternative method in the management of LPR. The study group consisted of 36 patients with symptoms and physical findings suggesting LPR. The control subjects were 23 healthy adults. Twenty-four-hour double-probe pH monitoring was performed both in the study group and the control group, and the results were compared. In addition, the symptoms and physical findings in the study group was scored by the modified reflux symptom index (MRSI) and reflux finding score (RFS) at four intervals: before the start of therapy and at the second, fourth and sixth months of the therapy. The results of the 24-hour double-probe pH monitoring showed no significant difference between the study and the control groups (p>0.05). In the study group, the MRSI before the therapy was 13.6+/-4.4. This index improved significantly to 4.3+/-1.9 at the second month; to 1.5+/-0.6 at the fourth month, and to 0.5+/-0.2 at the sixth month of the therapy (p<0.05). The RFS before the start of the therapy was 14.8+/-3.8; and it improved significantly to 7.7+/-3.8 at the second month; to 4.5+/-2.3 at the fourth month, and to 1.4+/-0.9 at the sixth month of the therapy (p<0.05). The significant improvement in the MRSI and the RFS during the course of proton pump inhibitor therapy relates the patients' symptoms and physical findings to LPR. This implies the validity of the method, not only in the treatment of LPR, but in the diagnosis of this disorder, as well. Unfortunately, 24-hour double-probe pH monitoring has failed to differentiate LPR patients from healthy individuals.
机译:喉咽反流(LPR)是一种相对常见的疾病,其定义为胃内容物回流到上消化道。但是,其诊断仍然存在许多问题。目前,二十四小时双探头pH监测是首选的诊断测试,但它有许多缺点。因此,已提出抗反流治疗的经验性试验作为诊断的替代方法。本文的目的是评估这种替代方法在LPR管理中的有效性。该研究组由36例症状和体征提示LPR的患者组成。对照对象是23名健康成年人。在研究组和对照组中均进行了24小时的双探针pH监测,并比较了结果。此外,研究组的症状和体格检查结果通过改良的反流症状指数(MRSI)和反流发现评分(RFS)在四个时间间隔进行评分:治疗开始前和治疗后第二,第四和第六个月治疗。 24小时双探针pH监测结果表明,研究组与对照组之间无显着差异(p> 0.05)。在研究组中,治疗前的MRSI为13.6 +/- 4.4。该指数在第二个月显着提高至4.3 +/- 1.9。在治疗的第四个月为1.5 +/- 0.6,在治疗的第六个月为0.5 +/- 0.2(p <0.05)。开始治疗前的RFS为14.8 +/- 3.8;第二个月显着提高到7.7 +/- 3.8;在治疗的第四个月为4.5 +/- 2.3,在治疗的第六个月为1.4 +/- 0.9(p <0.05)。在质子泵抑制剂治疗过程中,MRSI和RFS的显着改善将患者的症状和体征与LPR相关。这暗示了该方法的有效性,不仅在LPR的治疗中,而且在该疾病的诊断中也是如此。不幸的是,24小时双探头pH监测未能将LPR患者与健康个体区分开。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号